MedPath

A pilot study to investigate the role of androgens in the sexual functioning of women with primary ovary insufficiency (POI).

Conditions
POI, POF, sexual dysfunction
Registration Number
NL-OMON28298
Lead Sponsor
AMC, Amsterdam
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1. Participating in the POI-trial in Utrecht;

2. Being treated for POI at the AMC, Amsterdam.

Exclusion Criteria

1. Oophorectomy;

2. Severe relationship problems.

Study & Design

Study Type
Observational non invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Hormone levels:<br /><br>1. Estradiol;<br /><br>2. Total testosterone;<br /><br>3. Bio-available testosterone;<br /><br>4. SHBG;<br /><br>5. Androstenedione;<br /><br>6. Dehydroepiandrosterone sulfate.<br><br /><br /><br>Sexual function:<br /><br>1. Genital response by VPA;<br /><br>2. Subjective response by questionnaires, FSFI & FSDS-R.<br><br /><br /><br>Implicit association tasks:<br /><br>1. stIAT;<br /><br>2. PAT;<br /><br>3. Dot detection task.
Secondary Outcome Measures
NameTimeMethod
The feasibility of these tests in this group, measured by interview.
© Copyright 2025. All Rights Reserved by MedPath